Actively Recruiting
High Dimensional Analysis of Immune Cells in Pediatric Patients
Led by Seoul National University Hospital · Updated on 2024-11-29
294
Participants Needed
1
Research Sites
187 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to characterize immune cells using single-cell transcriptomic analysis in pediatric patients aged 2 to 18 years undergoing general anesthesia who are expected to receive Rocuronium, a non-depolarizing neuromuscular blocking agent, in the event of an allergic reaction.
CONDITIONS
Official Title
High Dimensional Analysis of Immune Cells in Pediatric Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients between the ages of 2 and 18 undergoing general anesthesia and surgery using the neuromuscular blocker, rocuronium.
You will not qualify if you...
- Patients who have received immunomodulators, immunosuppressants, or similar treatments.
- Patients with autoimmune diseases such as rheumatoid arthritis, lupus, or Behcet's disease.
- Patients who regularly take, or have taken within 4 weeks, medications that may affect the immune system including oral steroids and anti-inflammatories.
- Patients deemed by the Principal Investigator to be unsuitable for the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here